HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Edelsberg, J. Articles by Oster, G. Search for Related Content PubMed PubMed Citation Articles by Edelsberg, J. Articles by Oster, G.

JOHN EDELSBERG, M.D., M.P.H., is Medical Director; MAY HAGIWARA, PH.D., is Senior Analyst; CHARU TANEJA, M.P.H., is Research Associate; and GERRY OSTER, PH.D., is Vice President, Policy Analysis Inc., Brookline, MA.

Address correspondence to Dr. Oster at Policy Analysis Inc., Four Davis Court, Brookline, MA 02445 (goster{at}pai2.com).

Purpose. The 90-day risk of venous thromboembolism (VTE) among medically ill patients admitted to a hospital was estimated and is discussed. Summary. Patients aged 40 years who were hospitalized between January 1, 1998, and June 30, 2002, for reasons other than traumatic injury, labor and delivery, mental disorder, or VTE and who did not undergo surgery were identified in a large U.S. healthcare claims database. Patients receiving anticoagulants in the 90-day period preceding hospital admission were excluded. We estimated the percentage of study subjects who developed clinical deep-vein thrombosis (DVT) or pulmonary embolism (PE) within 90 days of hospital admission using Kaplan–Meier methods. We also estimated hazard ratios (HRs) for potential risk factors for VTE using univariate and stepwise multivariate Cox proportional hazards regression models. Among 92,162 study subjects, 1468 (1.59%) developed clinical DVT or PE within 90 days of hospital admission; 18% of these events occurred postdischarge. In multivariate analyses, significant risk factors for clinical VTE included: 1) history of cancer (HR, 1.67; 95% confidence interval [CI], 1.45–1.93); 2) history of VTE within six months of index admission (HR, 6.14; 95% CI, 4.74–7.96); 3) operating room procedure within 30 days of index admission (HR, 1.81; 95% CI, 1.47–2.24); 4) peripheral artery disease during index admission (HR, 1.68; 95% CI, 1.28–2.21); and 5) heart failure during index admission (HR, 1.72; 95% CI, 1.52–1.95). Conclusion. The risk of clinical VTE among medically ill patients admitted to a hospital, although less than that of patients undergoing major surgery, is not negligible. Patients with a history of recent VTE or surgery, those who are admitted to the intensive care unit, those with an admitting diagnosis of heart failure, and those with active cancer are at especially high risk of VTE and deserve increased consideration for prophylaxis. Index terms: Heart failure; Hospitals; Neoplasms; Peripheral vascular diseases; Surgery; Thromboembolism

 

This article has been cited by other articles:

				B. Park, L. Messina, P. Dargon, W. Huang, R. Ciocca, and F. A. Anderson Recent Trends in Clinical Outcomes and Resource Utilization for Pulmonary Embolism in the United States: Findings From the Nationwide Inpatient Sample Chest, October 1, 2009; 136(4): 983 - 990. [Abstract] [Full Text] [PDF]

				G. Piazza, E. J. Rosenbaum, W. Pendergast, J. O. Jacobson, R. C. Pendleton, G. D. McLaren, C. G. Elliott, S. M. Stevens, W. F. Patton, O. Dabbagh, et al. Physician Alerts to Prevent Symptomatic Venous Thromboembolism in Hospitalized Patients Circulation, April 28, 2009; 119(16): 2196 - 2201. [Abstract] [Full Text] [PDF]

				M. Masoud, G. Sarig, B. Brenner, and G. Jacob Orthostatic Hypercoagulability: A Novel Physiological Mechanism to Activate the Coagulation System Hypertension, June 1, 2008; 51(6): 1545 - 1551. [Abstract] [Full Text] [PDF]